| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| C6000041252 |
|
7355-18-2 |
METHYL 1,2,3,4-TETRA-O-ACETYL-BETA-D-GLUCURONATE - 98% |
0 | C15H20O11 | |
| C6000041251 |
|
53008-63-2 |
Methyl 2,3,4,6-Tetra-O-benzyl-a-D-galactopyranoside - 98% |
0 | C35H38O6 | |
| C6000041250 |
|
20031-21-4 |
1,2-O-Isopropylidene-alpha-D-xylofuranose - 98% |
0 | C8H14O5 | |
| C6000041249 |
|
526-99-8 |
MUCIC ACID - 98% |
0 | C6H10O8 | |
| C6000041248 |
|
10039-26-6 |
LACTOSE - 98% |
0 | C12H24O12 | |
| C6000041247 |
|
3615-37-0 |
D-( )-FUCOSE - 98% |
0 | C6H12O5 | |
| C6000041246 |
|
69313-67-3 |
Potassium lactobionate - 98% |
0 | C12H22KO12* | |
| C6000041245 |
|
87-73-0 |
D-Glucaric acid - 98% |
0 | C6H10O8 | |
| C6000041244 |
|
637334-45-3 |
Ocrelizumab - 98% |
0 | — | |
| C6000041243 |
|
1610943-06-0 |
Emicizumab - 98% |
0 | — | |
| C6000041242 |
|
1190264-60-8 |
dupilumab - 70%~130% |
0 | — | |
| C6000041241 |
|
1826843-81-5 |
Trastuzumab Deruxtecan - 98% |
0 | — | |
| C6000041240 |
|
1018448-65-1 |
Trastuzumab emtansine - 98% |
0 | — | |
| C6000041239 |
|
441-38-3 |
ALPHA-BENZOIN OXIME - 98% |
0 | C14H13NO2 | |
| C6000041238 |
|
15484-44-3 |
Sodium 2-chloroethanesulfonate monohydrate - 98% |
0 | 15484-44-3分子式C2H6ClNaO3S | |
| C6000041237 |
|
126-83-0 |
N/A - 98% |
0 | C3H8ClNaO4S | |
| C6000041236 |
|
114772-34-8 |
Methyl 4'-methylbiphenyl-2-carboxylate - 99% |
0 | C15H14O2 | |
| C6000041232 |
|
3415-08-5 |
L-Tyr-NCA - 98% |
0 | C10H9NO4 | |
| C6000041231 |
|
2224-52-4 |
(S)-4-Methyl-2,5-oxazolidonedione - 98% |
0 | C4H5NO3 | |
| C6000041230 |
|
93129-94-3 |
名：Tacalcitol monohydrate - 98% |
0 | C27H46O4 | |
